Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
67.08 USD | -0.07% | -0.01% | +7.79% |
May. 16 | Axonics Implant Approved in Australia to Treat Overactive Bladders | MT |
May. 16 | Axonics, Inc. Receives Regulatory Approval for Recharge-Free SNM System in Australia | CI |
Financials (USD)
Sales 2024 * | 447M | Sales 2025 * | 537M | Capitalization | 3.42B |
---|---|---|---|---|---|
Net income 2024 * | -1M | Net income 2025 * | 36M | EV / Sales 2024 * | 6.92 x |
Net cash position 2024 * | 329M | Net cash position 2025 * | 370M | EV / Sales 2025 * | 5.69 x |
P/E ratio 2024 * |
-2,134
x | P/E ratio 2025 * |
95.7
x | Employees | 797 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 98.93% |
Latest transcript on Axonics, Inc.
1 day | -0.07% | ||
1 week | -0.01% | ||
Current month | -0.01% | ||
1 month | -0.36% | ||
3 months | -0.81% | ||
6 months | +18.06% | ||
Current year | +7.79% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 51 | 12-12-31 | |
Raymond Cohen
FOU | Founder | 65 | 13-09-30 |
Kari Keese
DFI | Director of Finance/CFO | 39 | 13-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Carrel
CHM | Chairman | 53 | 19-02-26 |
Nancy Snyderman
BRD | Director/Board Member | 72 | 19-04-07 |
Raymond Cohen
FOU | Founder | 65 | 13-09-30 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.98% | 11 M€ | -6.03% | - | |
0.09% | 415 M€ | -.--% | ||
0.05% | 775 M€ | -.--% | - | |
0.04% | 248 M€ | +11.05% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-06-07 | 67.08 | -0.07% | 380,258 |
24-06-06 | 67.13 | -0.07% | 123,697 |
24-06-05 | 67.18 | +0.48% | 156,503 |
24-06-04 | 66.86 | +0.09% | 329,941 |
24-06-03 | 66.8 | -0.43% | 486,165 |
Delayed Quote Nasdaq, June 07, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+7.79% | 3.42B | |
+16.65% | 133B | |
-3.76% | 11.52B | |
-4.86% | 8.3B | |
-22.44% | 4.69B | |
-17.26% | 2.54B | |
-13.36% | 2.03B | |
-16.39% | 1.86B | |
-31.24% | 1.59B | |
-8.10% | 1.17B |
- Stock Market
- Equities
- AXNX Stock